Everything about Raw Materials
“The current scenario has uncovered some structural weaknesses in the EU’s medicines supply chain plus a large dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides reported. She encouraged that offer chain concerns be addressed within an EU pharmaceutical system anticipated for being released by the